Ryan Lynch serves as Executive at CONCERT PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Ryan Lynch has executed 8 insider transactions totaling $50.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 15, 2025 involved receiving (via award) 4,000 shares valued at $0.
Ryan Lynch currently holds 12,378 shares of CONCERT PHARMACEUTICALS, INC. (CNCE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan Lynch has been a net seller of CNCE stock. They have purchased $0 and sold $50.8K worth of shares.
Ryan Lynch's most recent insider trade was on Dec 15, 2025, when they sold 4,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 15, 2019 | CNCE | $0 | Award | 14,063 | $N/A | Discretionary |
| Mar 31, 2019 | CNCE | $12.6K | Payment | 1,043 | $12.07 | Discretionary |
| Mar 31, 2018 | CNCE | $22.0K | Payment | 961 | $22.90 | Discretionary |
| Sep 14, 2017 | CNCE | $50.8K | Sale | 3,500 | $14.51 | Discretionary |
| Sep 14, 2017 | CNCE | $33.1K | Option Exercise | 3,500 | $9.46 | Discretionary |
| Jul 6, 2017 | CNCE | $0 | Award | 6,000 | $N/A | Discretionary |